NSE · ONESOURCE
Onesource Specialty Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#397
of 5,004 stocks
▼ 61W
Peak #389 · 27 Sep 2026
Operating in Healthcare, Onesource Specialty Pharma Limited has a subdued return on equity, is well-owned by domestic institutions (23% DII), and is seeing revenue slip.
Market Cap
17,443.62 Cr
P/E Ratio
—
P/B Ratio
2.99
ROE
-1.27%
ROCE
0.59%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 449.02 Cr | 428.22 Cr | 290.34 Cr | 375.76 Cr |
| Net Profit | 25.00 Cr | 4.60 Cr | -88.70 Cr | 10.48 Cr |
| EPS | 2.18 | 0.40 | -7.74 | 0.92 |
| Operating Profit | 55.40 Cr | 22.19 Cr | -47.69 Cr | 39.70 Cr |
Shareholding pattern
Promoter
30.48%
Public
69.52%
PUBLIC BREAKDOWN
FII
19.19%
DII
23.38%
MF (within DII)
12.98%
Individuals
12.11%
Mutual fund holdings
₹2,222.21
Cr total
78
Schemes
23
Fund Houses
₹2,222.21 Cr
Total Exposure
Motilal Oswal Mutual Fund₹1,204.95 Cr (54.2%)
Axis Mutual Fund₹230.77 Cr (10.4%)
360 ONE Mutual Fund₹202.71 Cr (9.1%)
Mirae Asset Mutual Fund₹196.06 Cr (8.8%)
Aditya Birla Sun Life Mutual Fund₹158.41 Cr (7.1%)
Others₹229.31 Cr (10.3%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.